CAR-T cell therapy for glioblastoma: insight from mathematical modeling
IntroductionGlioblastoma is a rare, aggressive brain tumor marked by high therapeutic resistance, poor prognosis, and limited treatment options. Emerging immunotherapies, particularly Chimeric Antigen Receptor (CAR) T-cell therapy, offer promising alternatives to standard care. However, adapting CAR...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2025-06-01
|
| Collection: | Frontiers in Immunology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1563829/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|